Patent · US Active

Anti-amyloid antibodies and uses thereof

US8414893B2 · kind B2 · utility

16Cited by

69References

20Claims

0Family size

Assignee

AMGEN INC. · US

Inventors

Anja Leona Biere-Citron · Thousand Oaks, US
Frederick W. Jacobsen · Newbury Park, US
Stephen J. Wood · Cadillac, US

Key dates

Filing date	Dec 19, 2008
Grant date	Apr 9, 2013
Priority date	—
Expiry date	Dec 19, 2028

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K2317/92
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Compositions for treating neurodegenerative or amyloidogenic disorders such as Alzheimer's disease (AD) are provided. More particularly, anti-amyloid-beta antibodies, compositions containing such antibodies, corresponding nucleic acids, vectors and host cells, and methods of making such antibodies are provided.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.